Abstract
Pancreatic neuroendocrine tumors are a group of rare neoplasms originating from the neuroendocrine cells of pancreas. They can be classified into functioning or non-functioning groups according to hormone secretion. Due to the application of high-resolution imaging techniques, the incidence of incidental non-functioning pancreatic neuroendocrine tumors has been rising for decades. Although the optimal prognosis, non-functioning pancreatic neuroendocrine tumor are heterogeneous, and the complication morbidity is high. So controversy still exists for the choice of treatment approach. This article aims to summarize and analyze the progress and current controversy about the treatment of incidental non-functioning pancreatic neuroendocrine tumors, and discuss about the appropriate treatment choice for patients. Key words: Pancreatic neuroendocrine neoplasms; Non-function; Therapy; Follow-up
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
